Read here.Read more →
CLS is a Swedish high-tech medical device company that has been in operation since 2006 within the dynamic landscape between sophisticated medical technology and advanced medical treatment.
Clinical Laserthermia Systems (CLS) (publ), which develops and markets Interstitial Laser Thermo Therapy (imILTCLS), a polyclinical, heat-induced cancer immunotherapy for gentle and effective treatment , has received approval from the US Food and Drug Administration (FDA), via an 510(k) application, for the latest version of the TRANBERGCLS Laser Fiber product, a radial fiber developed byRead more →
Our mission is to provide products that improve treatment for cancer patients by offering significant and long-lasting health benefits, while reducing cost-of-care for society. The company was founded based on the results of 20 years of intense research within immunotherapy and thermotherapy.
imILTCLS (immunostimulating Interstitial Laser Thermotherapy by CLS) is a new, promising treatment in the growing field of cancer immunotherapy. The minimally invasive, thermal treatment is performed using the TRANBERGCLS | Cancer Immunotherapy System designed to achieve local tumor destruction and specific anti-tumor immunity.